Physiopathogenic mechanisms and laboratorial diagnosis of Entamoeba histolytica infection;Mecanismos fisiopatogênicos e diagnóstico laboratorial da infecção causada pela Entamoeba histolytica

Jornal Brasileiro de Patologia e Medicina Laboratorial

Volumn 44, Issue 4, 2008, Pages 249-261

  Santos, Fred Luciano Neves ^a,c   Soares, Neci Matos ^b  

^a Faculdades Integradas da Bahia (FIB)   (Brazil)

^b FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^c Laboratório de Bioquímica Clínica   (Brazil)

Author keywords

Amebiasis; Entamoeba histolytica; Physiopathogeny

Indexed keywords

EID: 59849125140     PISSN: 16762444     EISSN: 16784774     Source Type: Journal    
DOI: 10.1590/S1676-24442008000400004     Document Type: Review

References (124)

1. ABD-ALLA , M. D.; RAVDIN, J. I. Diagnosis of amoebic colitis by antigen capture ELISA in patients presenting with acute diarrhea in Cairo, Egypt. Trop Med Int Health, v. 7, n. 4, p. 365-70, 2002.
2. ABIOYE, A. A. Fatal amoebic colitis in pregnancy and puerperium: a new clinico-pathological entity. J Trop Med Hyg, v. 76, n. 4, p. 97-100, 1973.
3. ACKERS, J. P. The diagnostic implications of the separation of Entamoeba histolytica and Entamoeba dispar. J Biosci, v. 27, n. 6, suppl. 3, p. 573-8, 2002.
4. ADAMS, E. B.; MACLEOD, I. N. Invasive amebiasis. II. Amebic liver abscess and its complications. Medicine (Baltimore), v. 56, n. 4, p. 325-34, 1977a.
5. ADAMS, E. B.; MACLEOD, I. N. Invasive amebiasis. I. Amebic dysentery and its complications. Medicine (Baltimore), v. 56, n. 4, p. 315-23, 1977b.
6. ALLASON-JONES, E. et al. Entamoeba histolytica as a commensal intestinal parasite in homosexual men. N Engl J Med, v. 315, n. 6, p. 353-6, 1986.
7. ARGENZIO, R. A. et al. Prostanoids inhibit intestinal NaCl absorption in experimental porcine cryptosporidiosis. Gastroenterology, v. 104, n. 2, p. 440-7, 1993.
8. ARISTIZABAL, H. et al. Fulminant amebic colitis. World J Surg, v. 15, n. 2, p. 216-21, 1991.
9. BANK, S. et al. The clinical spectrum of amoebic colitis. S Afr Med J, v. 45, n. 9, p. 219-25, 1971.
10. BAPAT, M. M.; BHAVE, G. G. Counterimmunoelectrophoresis in the immunodiagnosis of amoebiasis. J Postgrad Med, v. 36, n. 3, p. 124-7, 1990.
11. BENETTON, M. L. et al. Risk factors for infection by the Entamoeba histolytica/E. dispar complex: an epidemiological study conducted in outpatient clinics in the city of Manaus, Amazon Region, Brazil. Trans R Soc Trop Med Hyg, v. 99, n. 7, p. 532-40, 2005.
12. BERNINGHAUSEN, O.; LEIPPE, M. Necrosis versus apoptosis as the mechanism of target cell death induced by Entamoeba histolytica. Infect Human, v. 65, n. 9, p. 3615-21, 1997.
13. BEUBLER, E. et al. Involvement of 5-hydroxytryptamine, prostaglandin E2 and cyclic adenosine monophosphate in cholera toxin-induced fluid secretion in the small intestine of the rat in vivo. Gastroenterology, v. 96, p. 368-76, 1989.
14. BEUBLER, E. et al. Cholera toxin induces prostaglandin synthesis via posttranscriptional activation of cyclooxygenase-2 in the rat jejunum. J Pharmacol Exp Ther, v. 297, n. 3, p. 940-45, 2002.
15. BHATTACHARYA, A. et al. Absence of lipophosphoglycan-like glycoconjugates in Entamoeba histolytica. Parasitology, v. 120, p. 31-5, 2000.
16. BRAGA, L. L. et al. Seroepidemiology of Entamoeba histolytica in a slum in northeastern Brazil. Am J Trop Med Hyg, v. 55, n. 6, p. 693-7, 1996.
17. BRAGA, L. L. et al. Entamoeba histolytica and Entamoeba dispar infections as detected by monoclonal antibody in an urban slum in Fortaleza, Northeast Brazil. Rev Soc Bras Med Trop, v. 34, n. 5, p. 467-71, 2001.
18. CABALERO-SALCEDO, A. et al. Seroepidemiology of amebiasis in Mexico. Am J Trop Med Hyg, v. 50, n. 4, p. 412-9, 1994.
19. CALALB, M. B. et al. Tyrosine phosphorylation of focal adhesion kinase at sites in the catalytic domain regulates kinase activity: a role for Src kinases. Mol Cell Biol, v. 15, n. 2, p. 954-63, 1995.
20. CAMPOS-RODRÍGUEZ, R.; JARILO-LUNA, A. The pathogenicity of Entamoeba histolytica is related to the capacity of evading innate immunity. Parasite Immunol, v. 27, p. 1-8, 2005.
21. CARDOSO, J. M. et al. Radiology of invasive amebiasis of the colon. Am J Roentgenol, v. 128, n. 6, p. 935-41, 1977.
22. CHADEE, K. et al. Rat and human colonic mucins bind to and inhibit the adherence lectin of Entamoeba histolytica. J Clin Invest, v. 80, n. 5, p. 1245-54, 1987.
23. CUMMINS, A. J. Rapid latex agglutination test for extraluminal amoebiasis. J Clin Pathol, v. 47, n. 7, p. 647-8, 1994.
24. DENIS, M.; CHADEE, K. In vitro and in vivo studies of macrophage functions in amebiasis. Infect Immun, v. 56, p. 3126-31, 1988.
25. ELLYSON, J. H. et al. Necrotizing amebic colitis: a frequently fatal complication. Am J Surg, v. 152, n. 1, p. 21-6, 1986.
26. EVANGELOPOULOS, A. et al. A nested, multiplex, PCR assay for the simultaneous detection and differentiation of Entamoeba histolytica and Entamoeba dispar in faeces. Ann Trop Med Parasitol, v. 94, n. 3, p. 233-40, 2000.
27. EVANGELOPOULOS, A. et al. Microscopy, PCR and ELISA applied to the epidemiology of amebiasis in Greece. Parasitol Int, v. 50, n. 3, p. 185-9, 2001.
28. FERREIRA, C. B.; MARÇAL, J. R. Enteroparasitoses em escolares do distrito de Martinésia, Uberlândia-MG: um estudo-piloto. Rev Soc Bra Med Trop, v. 30, n. 5, p. 373-7, 1997.
29. GARCIA, L. S.; BRUCKNER, D. A. Diagnostic medical parasitology. 3. ed. Washington, D.C.: ASM Press, 1997.
30. GATHIRAM, V.; JACKSON, T. F. A longitudinal study of asymptomatic carriers of pathogenic zymodemes of Entamoeba histolytica. S Afr Med J, v. 72, n. 10, p. 669-72, 1987.
31. GONZÁLEZ-RUIZ, A. et al. Value of microscopy in the diagnosis of dysentery associated with invasive Entamoeba histolytica. J Clin Pathol, v. 47, n. 3, p. 236-9, 1994a.
32. GONZÁLEZ-RUIZ, A. et al. Diagnosis of amebic dysentery by detection of Entamoeba histolytica fecal antigen by an invasive strain-specific, monoclonal antibody-based enzyme-linked immunosorbent assay. J Clin Microbiol, v. 32, n. 4, p. 964-70, 1994b.
33. GUERRANT, R. L. et al. Interaction between Entamoeba histolytica and human polymorphonuclear neutrophils. J Infec Dis, v. 143, n. 1, p. 83-93, 1981.
34. HAQUE, R. et al. Rapid diagnosis of Entamoeba infection using Entamoeba and Entamoeba histolytica stool antigen detection kits. J Clin Microbiol, v. 33, n. 10, p. 2558-61, 1995.
35. HAQUE, R. et al. Comparison of PCR, isoenzyme analysis and antigen detection for diagnosis of Entamoeba histolytica infection. J Clin Microbiol, v. 36, n. 2, p. 449-52, 1998.
36. HAQUE, R. et al. Prevalence and immune response to Entamoeba histolytica infection in preschool children in Bangladesh. Am J Trop Hyg, v. 60, p. 1031-4, 1999.
37. HAQUE, R. et al. Diagnosis of amebic liver abscess and intestinal infection with the TechLab Entamoeba histolytica II antigen detection and antibody tests. J Clin Microbiol, v. 38, n. 9, p. 3235-9, 2000.
38. HAQUE, R. et al. Innate and acquired resistance to amoebiasis in Bangladeshi children. J Infect Dis, v. 186, n. 4, p. 547-52, 2002.
39. HUNG, C. C. et al. Invasive amoebiasis: an emerging parasitic disease in patients infected with HIV in an area endemic for amoebic infection. AIDS, v. 13, n. 17, p. 2421-8, 1999.
40. JACKSON, T. F. et al. Serological differentiation between past and present infection in hepatic amoebiasis. Tran R Soc Trop Med Hyg, v. 78, n. 3, p. 342-5, 1984.
41. JACKSON, T. F. et al. Seroepidemiological study of antibody responses to the zymodemes of Entamoeba histolytica. Lancet, v. 1, n. 8431, p. 716-9, 1985.
42. JAMMAL, M. A. et al. Amebiasis presenting as rectal bleeding without diarrhea in childhood. J Pediatr Gastroenterol Nutr, v. 4, n. 2, p. 294-6, 1985.
43. JETTER, A. et al. An epidemiological study of Entamoeba histolytica and E. dispar infection in eastern Turkey using a colorimetric polymerase chain reaction. Arch Med Res, v. 28, p. 319-21, 1997.
44. KAPOOR, O. P. Amebic liver abscess. Bombay Hospital Journal, v. 332, p. 5-8, 1990.
45. KATZWINKEL-WLADARSCH, S. et al. Direct amplification and differentiation of pathogenic and nonpathogenic Entamoeba histolytica DNA from stool specimens. Am J Trop Med Hyg, v. 51, p. 115-8, 1994.
46. KEENE, W. E. et al. The major neutral proteinase of Entamoeba histolytlca. J Exp Med, v. 163, n. 3, p. 536-49, 1986.
47. KELSAL, B. L.; RAVDIN, J. L. Degradation of human IgA by Entamoeba histolytica. J Infect Dis, v. 168, n. 5, p. 1319-22, 1993.
48. KNOBLOCH, J.; MANNWEILER, E. Development and persistence of antibodies to Entamoeba histolytica in patients with amebic liver abscess: Analysis of 216 cases. Am J Trop Med Hyg, v. 32, n. 4, p. 727-32, 1983.
49. KRETSCHMER, R. et al. Inhibition of monocyte locomotion by products of axenically grown Entamoeba histolytica. Parasite Immunol, v. 7, n. 5, p. 527-43, 1985.
50. KRETSCHMER, R. R. et al. A novel anti-inflammatory oligopeptide produced by Entamoeba histolytica. Mol Bioch Parasitol, v. 112, n. 2, p. 201-9, 2001.
51. KROGSTAD, D. J. et al. Amebiasis: epidemiologic studies in the United States, 1971-1974. Ann Inter Med, v. 88, n. 1, p. 89-97, 1978.
52. LAFLAMME, S. E.; AUER, K. L. Integrin signaling. Seminars in Cancer Biology, v. 7, n. 3, p. 111-8, 1996.
53. LEIPPE, M. et al. Primary and secondary structure of the pore-forming peptide of pathogenic Entamoeba histolytica. EMBO J, v. 11, n. 10, p. 3501-6, 1992.
54. LEIPPE, M. et al. Amoebapores, a family of membranolytic peptides from cytoplasmic granules of Entamoeba histolytica: isolation, primary structure, and pore formation in bacterial cytoplasmic membranes. Mol Microbiol, v. 14, n. 5, p. 895-904, 1994.
55. LEIPPE, M. Ancient weapons: the three-dimensional structure of amoebapore A. Trends in Parasitol, v. 21, n. 1, p. 5-7, 2005.
56. LEROY, A. et al. Entamoeba histolytica disturbs the tight junction complex in human enteric T84 cell layers. FASEB J, v. 14, n. 9, p. 1139-46, 2000.
57. LEWIS, E. A.; ANTIA, A. U. Amoebic colitis: review of 295 cases. Trans R Soc Trop Med Hyg, v. 63, p. 633-8, 1969.
58. LI, E. et al. Entamoeba histolytica interactions with polarized human intestinal Caco-2 epithelial cells. Infect Immun, v. 62, n. 11, p. 5112-9, 1994.
59. LOTTER, H. et al. Crude or recombinant proteins applied to latex agglutination, complement-fixation and enzymelinked immunosorbent assays for the serodiagnosis of invasive amebiasis. Trop Med Parasitol, v. 44, n. 4, p. 277-80, 1993.
60. LOTTER, H. et al. Evaluation of three serological tests for the detection of antiamebic antibodies applied to sera of patients from an area endemic for amebiasis. Trop Med Parasitol, v. 46, n.3, p. 180-2, 1995.
61. MARKELL, E. K. et al. Protozoários que habitam a luz. In: MARKELL. Parasitologia médica. 8. ed. Rio de Janeiro: Guanabara-Koogan, 2003.
62. McGEE, D. W. Inflammation and mucosal cytokine production. In: OGRA , P. L. et al. (ed.). Mucosal immunology. San Diego: Academic Press Inc., 1999. p. 559-73.
63. MERRITT, R. J. et al. Spectrum of amebiasis in children. Am J Dis Child, v. 136, n. 9, p. 785-9, 1982.
64. MIRELMAN, D. et al. Comparison of use enzyme-linked immunosorbent assay-based kits and PCR amplification of rRNA genes for simultaneous of Entamoeba histolytica and E. dispar. J Clin Microbiol, v. 35. n. 9, p. 2405-7, 1997.
65. MOODY, S. et al. An improved colorimetric PCR-based method for detection and differentiation of Entamoeba histolytica and Entamoeba dispar in feces. J Clin Microbiol, v. 35, n. 5, p. 1108-11, 1997.
66. MOODY-HAUPT, S. et al. The major surface antigens of Entamoeba histolytica trophozoites are GPI-anchored proteophosphoglycans. J Mol Biol, v. 297, n. 2, p. 409-20, 2000.
67. MONTEIRO, L. et al. Complex polysaccharides as PCR inhibitors in feces: Helicobacter pylori model. J Clin Microbiol, v. 35, n. 4, p. 995-8, 1997.
68. OHNISHI, K.; MURATA, M. Present characteristics of symptomatic amebiasis due to Entamoeba histolytica in the east-southeast area of Tokyo. Epidemiol Infect, v. 119, n. 3, p. 363-7, 1997.
69. OJCIUS, D. M.; YOUNG, J. D. Cytolytic pore-forming proteins and peptides: is there a common structural motif? Trends Biochem Sci, v.16, p. 225-9, 1991.
70. OLIVEIRA-COSTA, J. et al. Prevalência de Entamoeba histolytica e Entamoeba dispar em amostras fecais de um laboratório privado na Grande Belo Horizonte. Semana de Iniciação Científica da Universidade Federal de Minas Gerais, Belo Horizonte-MG, 2006.
71. ORTIZ-ORTIZ, L. et al. Cell-mediated immunity in patients with amebic abscess of the liver. Clin Immunol Immunopathol, v. 4, p. 127-34, 1975.
72. PAL, S. et al. Comparative evaluation of somatic and excretory-secretory antigens of Entamoeba histolytica in serodiagnosis of human amoebiasis by ELISA. Indian J Med Res, v. 104, p. 152-6, 1996.
73. PARIJA, S. C.; KARKI, B. M. Detection of circulating antigen in amoebic liver abscess by counter-current immunoelectrophoresis. J Med Microbiol, v. 48, n. 1, p. 99-101, 1999.
74. PETRI, W. A. et al. Estimating the impact of amebiasis on health. Parasitol Today, v. 16, n. 8, p. 320-1, 2000.
75. PHIPPS, R. P. et al. A new view of prostaglandin E regulation of the immune response. Immunol Today, v. 12, p. 349-52, 1991.
76. PINHEIRO, S. M. et al. Determination of the prevalence of Entamoeba histolytica and E. dispar in the Pernambuco State of Northeastern Brazil by a polymerase chain reaction. Am J Trop Med Hyg, v. 70, n. 2, p. 221-4, 2004.
77. PRASAD, R. et al. Recognition of Entamoeba histolytica lipophosphoglycan by a strain-specific monoclonal antibody and human immune sera. Mol Biochem Parasitol, v. 56, p. 279-87, 1992.
78. PROCTOR, E. M. Laboratory diagnosis of amebiasis. Clin Lab Med, v. 11, n. 4, p. 829-59, 1991.
79. QUE, X.; REED, S. L. The role of extracelular cysteine proteinases in pathogenesis of Entamoeba histolytica invasion. Parasitol Today, v. 13, n. 5, p. 190-4, 1997.
80. QUE, X.; REED, S. L. Cysteine proteinases and the pathogenesis of amebiasis. Clin Microbiol Rev, v. 13, n. 2, p. 196-206, 2000.
81. RAMOS, F. et al. The effect of formalin fixation on the polymerase chain reaction characterization of Entamoeba histolytica. Trans Med Roy Soc Hyg, v. 93, p. 335-3, 1999.
82. RAVDIN, J. L. Cytopathogenic mechanism of Entamoeba histolytica. J Exp Med, v. 152, n. 2, p. 377-90, 1980.
83. RAVDIN, J. I. et al. Adherence of Entamoeba histolytica trophozoites to rat and human colonic mucosa. Infect Immun, v. 48, n. 2, p. 292-7, 1985.
84. RAVDIN, J. L. Amebiasis. Clin Infect Dis, v. 20, n. 6, p. 1453-66, 1995.
85. REED, S. L. et al. Entamoeba histolytica infection and AIDS. Am J Med, v. 90, n. 2, p. 269-71, 1991.
86. RESTREPO, M. I. et al. Diagnostic tests for amoebic liver abscess: comparison of enzyme-linked immunosorbent assay (ELISA) and counterimmunoelectrophoresis (CIE). Rev Soc Bras Med Trop, v. 29, n. 1, p. 27-32, 1996.
87. RICO, G. et al. Effect of the monocyte locomotion inhibitory factor (MLIF) produced by Entamoeba histolytica upon the respiratory burst of human leukocytes. Arch Med Res, v. 23, n. 2, p. 157-9, 1992.
88. RICO, G. et al. The effect of the monocyte locomotion inhibitory factor (MLIF) produced by Entamoeba histolytica upon nitric oxide production by human leukocytes. Arch Med Res, v. 31, p. S90-1, 2000.
89. ROSENBERG, I. et al. Isolation, characterization and partial purification of a transferable membrane channel (amoebapore) produced by Entamoeba histolytica. Mol Biochem Parasitol, v. 33, n. 3, p. 237-47, 1989.
90. ROLLINS, S. A. et al. Inhibition of homologous complement by CD59 is mediated by a species-specific recognition conferred through binding to C8 within C5b-8 or C9 within C5b-9. J Immunol, v. 146, n. 7. p. 2345-51, 1991.
91. ROY, S. et al. Real-time-PCR assay for diagnosis of Entamoeba histolytica infection. J Clin Micorbiol, v. 43, n. 5, p. 2168-72, 2005.
92. SALATA, R. A. et al. Interaction of human leukocytes and Entamoeba histolytica: killing of virulent amebae by the activated macrophage. J Clin Invest, v. 76, n. 2, p. 491-9, 1985.
93. SALATA, R. A. et al. Suppression of T-lymphocyte responses to Entamoeba histolytica antigen by immune sera. Infect Immun, v. 58, p. 3941-6, 1990.
94. SALES, J. M. et al. Hepatic amebiasis. Brazilian Journal of Infectious Diseases, v. 7, p. 96-110, 2003.
95. SANTOS, F. L. et al. Comparison of the thick smear and Kato-Katz techiniques for diagnosis of intestinal helminth infections. Rev Soc Bras Med Trop, v. 38, n. 2, p. 196-8, 2005.
96. SANTOS, F. L. Implantação e avaliação do diagnóstico diferencial entre Entamoeba histolytica e Entamoeba dispar em amostras fecais. 2007. Dissertação (mestrado) - Faculdade de Medicina, Universidade Federal da Bahia, Salvador.
97. SÉGUIN, R. et al. Entamoeba histolytica stimulates the unstable transcription of c-fos and tumor necrosis factor-a messenger RNA by protein kinase C signal transduction in macrophages. Immunology, v. 86, p. 49-57, 1995.
98. SEYDEL, K. B. et al. Human intestinal epithelial cells produce proinflammatory cytokines in response to infection in a SCID mouse-human intestinal xenograft model of amebiasis. Infect Immun, v. 65, n. 5, p. 1631-9, 1997.
99. SHARMA, M. et al. Enhanced pro-inflammatory chemokine/cytokine response triggered by pathogenic Entamoeba histolytica: basis invasive disease. Parasitology, v. 131, n. 6, p. 783-96, 2005.
100. SILVA, M. C. et al. Determination of Entamoeba histolytica infection in patients from Greater Metropolitan Belém, Pará, Brazil, by enzyme-linked immunosorbent assay (ELISA) for antigen detection. Cad Saúde Pública, v. 21, n. 3, p. 969-73, 2005.
101. SRIVASTAVA, G. et al. Lipophosphoglycan is present in distinctly different form in different Entamoeba histolytica strains and absent in Entamoeba moshkovskii and Entamoeba invadens. J Eukaryot Microbiol, v. 42, n. 5, p. 617-22, 1995.
102. STANLEY, S. L. Amoebiasis. Lancet, v. 361, n. 9362, p. 1025-34, 2003.
103. STENSON, W. F. et al. Amebic infection in the human colon induces cyclooxygenase-2. Infect Immun, v. 69, n. 5, p. 3382-8, 2001.
104. TACHIBANA, H. et al. Asymptomatic cyst passers of Entamoeba histolytica but not Entamoeba dispar in institutions for the mentally retarded in Japan. Parasitol Int, v. 49, n. 1, p. 31-5, 2000.
105. TAKAHASHI, T. et al. Fulminant amebic colitis: analysis of 55 cases. Dis Colon Rectum, v. 40, n. 11, p. 1362-7, 1997.
106. TALVANI, A. et al. Chemokine receptor expression on the surface of peripheral blood mononuclear cells in Chagas disease. J Infect Dis, 189: 214-220, 2004.
107. TANYUKSEL, M. et al. Comparison of the serologic tests (IFA, ELISA) with microscopy using for the diagnosis of amoebosis. Acta Parasitol Turc, v. 19, p. 476-2, 1995.
108. TAVAERS, P. et al. Cell polarization and adhesion in a motile pathogenic protozoan: role and fate of the Entamoeba histolytica Gal/GalNac lectin. Microbes and Infection, v. 2, n. 6, p. 643-9, 2000.
109. TRISSL, D. et al. Surface properties of Entamoeba: increased rates of human erythrocyte phagocytosis in pathogenic strain. J Exp Med, v. 148, n. 5, p. 1137-43, 1978.
110. VALLE, P. R. et al. Arbitrarily primed PCR fingerprinting of RNA and DNA in Entamoeba histolytica. Rev Inst Med Trop São Paulo, v. 42, n. 5, p. 249-53, 2000.
111. VERWEIJ, J. J. et al. Differentiation of Entamoeba histolytica and Entamoeba dispar cysts using polymerase chain reaction on DNA isolated from faeces with spin columns. Eur J Clin Microbiol Infect Dis, v. 19, p. 358-61, 2000.
112. WALDERICH, B. et al. Differentiation of Entamoeba histolytica and Entamoeba dispar from German travelers and residents of endemic regions. Am J Trop Med Hyg, v. 57, n. 1, p. 70-4, 1997.
113. WALSH, J. A. Problems in recognition and diagnosis of amebiasis: estimation of the global magnitude of morbidity and mortality. Rev Infect Dis, v. 8, n. 2, p.228-38, 1986.
114. WALSH, J. A. Prevalence of Entamoeba histolytica infection. In: RAVDIN, J. I. (ed.). Amebiasis: human infection by Entamoeba histolytica. New York: John Wiley and Sons, p. 93-105, 1988.
115. WANG, W.; CHADEE, K. Entamoeba histolytica alters arachidonic acid metabolism in macrophages in vitro and in vivo. Immunology, v. 76, p. 242-50, 1992.
116. WANG, W. Modulation of tumor necrosis factor production by macrophages in Entamoeba histolytica infection. Infect Immun, v. 60, p. 3169-74, 1992.
117. WANG, W. et al. Entamoeba histolytica modulates the nitric oxide synthase gene and nitric oxide production by macrophages for cytotoxicity against amoebae and tumour cells. Immunology, v. 83, p. 601-10, 1994.
118. WANG, W.; CHADEE, K. Entamoeba histolytica suppresses gamma interferon-induced macrophage class II major histocompatibility complex Ia molecule and I-Ab mRNA expression by a prostaglandin E2-dependent mechanism. Infect Immun, v. 63, p. 1089-94, 1995.
119. WEINKE, T. et al. Prevalence and clinical importance of Entamoeba histolytica in two high-risk groups: travelers returning from tropics and male homosexuals. J Infec Dis, v. 161, n. 5, p. 1029-31, 1990.
120. WELCH, J. S. et al. Immunodiagnosis of Entamoeba histolytica and Ascaris lumbricoides infections in Caucasian and aboriginal Australians. Trans R Soc Trop Med Hyg, v. 80, n. 2, p. 240-7, 1986.
121. WILSON, I. G. Inhibition and facilitation of nucleic acid amplification. Appl Envirol Microbio, v. 63, n. 10, p. 3741-51, 1997.
122. WORLD HEALTH ORGANIZATION. Amoebiasis. Report on the WHO /Pan American Health Organization/UNESCO Expert Consultation, Mexico City. Geneva-WHO. W Epidemiol Rec, v. 72, p. 97-100, 1997.
123. YOUNG, J. D. et al. Characterization of a membrane pore-forming protein from Entamoeba histolytica. J Exp Med, v. 156, n. 6, p. 1677-90, 1982.
124. ZENGZHU, G. et al. Analysis by enzyme-linked immunosorbent assay and PCR of human liver abscess aspirates from patients in China for Entamoeba histolytica. J Clin Microbiol, v. 37, n. 9, p. 3034-6, 1999.